X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-19 | CTMX | Rowland Lloyd A | GC | S - Sale | $2.09 | -5,268 | 117,728 | -4% | -$10,986 | ||||||
2024-03-19 | CTMX | McCarthy Sean A. | CEO | S - Sale | $2.09 | -20,223 | 617,639 | -3% | -$42,175 | ||||||
2024-03-19 | CTMX | Ogden Christopher | SVP, Finance, Accounting | S - Sale | $2.09 | -2,971 | 85,686 | -3% | -$6,196 | ||||||
2024-03-19 | CTMX | Belvin Marcia | SVP, Chief Scientific Officer | S - Sale | $2.09 | -12,795 | 168,579 | -7% | -$26,684 | ||||||
2024-03-19 | CTMX | Landau Jeffrey B | Chief Business Officer | S - Sale | $2.09 | -6,562 | 117,740 | -5% | -$13,685 | ||||||
2023-12-20 | CTMX | McCarthy Sean A. | CEO | S - Sale | $1.38 | -13,551 | 547,862 | -2% | -$18,710 | ||||||
2023-12-20 | CTMX | Belvin Marcia | SVP, Chief Scientific Officer | S - Sale | $1.38 | -4,077 | 155,124 | -3% | -$5,628 | ||||||
2023-12-20 | CTMX | Landau Jeffrey B | Chief Business Officer | S - Sale | $1.38 | -4,077 | 94,302 | -4% | -$5,628 | ||||||
2023-12-20 | CTMX | Rowland Lloyd A | GC | S - Sale | $1.38 | -4,077 | 97,996 | -4% | -$5,629 | ||||||
2023-12-20 | CTMX | Ogden Christopher | SVP, Finance, Accounting | S - Sale | $1.38 | -1,990 | 48,657 | -4% | -$2,747 | ||||||
2023-09-22 | CTMX | Belvin Marcia | SVP, Chief Scientific Officer | S - Sale | $1.30 | -4,119 | 147,951 | -3% | -$5,356 | ||||||
2023-09-22 | CTMX | Landau Jeffrey B | Chief Business Officer | S - Sale | $1.30 | -4,119 | 84,059 | -5% | -$5,356 | ||||||
2023-09-22 | CTMX | McCarthy Sean A. | CEO | S - Sale | $1.30 | -14,601 | 523,913 | -3% | -$18,987 | ||||||
2023-09-22 | CTMX | Rowland Lloyd A | GC | S - Sale | $1.30 | -5,486 | 80,609 | -6% | -$7,135 | ||||||
2023-03-29 | CTMX | Jones Elaine V | Dir | P - Purchase | $1.55 | +5,000 | 5,142 | >999% | +$7,750 | ||||||
2023-03-16 | CTMX | Ogden Christopher | SVP, Finance, Accounting | S - Sale | $1.98 | -516 | 37,772 | -1% | -$1,021 | ||||||
2023-03-16 | CTMX | McCarthy Sean A. | CEO | S - Sale | $1.88 | -7,121 | 481,979 | -1% | -$13,391 | ||||||
2023-03-16 | CTMX | Campoy Carlos | CFO | S - Sale | $1.98 | -1,748 | 38,224 | -4% | -$3,459 | ||||||
2023-03-16 | CTMX | Rowland Lloyd A | GC | S - Sale | $1.98 | -2,037 | 71,095 | -3% | -$4,031 | ||||||
2023-03-16 | CTMX | Landau Jeffrey B | CFO | S - Sale | $1.98 | -1,477 | 76,928 | -2% | -$2,923 | ||||||
2023-03-16 | CTMX | Peterson Amy C. | EVP, Chief Development Officer | S - Sale | $1.98 | -4,257 | 58,433 | -7% | -$8,425 | ||||||
2022-07-20 | CTMX | Peterson Amy C. | EVP, Chief Development Officer | S - Sale | $1.42 | -7,463 | 62,690 | -11% | -$10,612 | ||||||
2022-07-20 | CTMX | Landau Jeffrey B | Chief Business Officer | S - Sale | $1.42 | -4,206 | 38,405 | -10% | -$5,982 | ||||||
2022-07-20 | CTMX | McCarthy Sean A. | Pres, CEO | S - Sale | $1.42 | -14,911 | 384,100 | -4% | -$21,206 | ||||||
2022-07-20 | CTMX | Rowland Lloyd A | GC | S - Sale | $1.42 | -5,602 | 43,689 | -11% | -$7,968 | ||||||
2022-07-20 | CTMX | Hannah Alison L. | Chief Medical Officer | S - Sale | $1.42 | -5,602 | 31,898 | -15% | -$7,965 | ||||||
2022-07-20 | CTMX | Campoy Carlos | CFO | S - Sale | $1.42 | -3,949 | 39,972 | -9% | -$5,617 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |